News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Trefis Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Boston Scientific Corporation (NYSE:BSX) fell 2.3% in early trading on September 8, 2026, after disclosing that an August 25 cyberattack disrupted manufacturing and shipping. The company stated it is unlikely to meet its previously issued third-quarter and full-year 2026 guidance for net sales and โฆ
Image from Pixabay Boston Scientific (BSX) trades at about $43, roughly 17% below the recent high it set on 19th Aug, 2026. Its own history with sharp drops is encouraging. That history does not cover a cyberattack it says is likely to hit its โฆ
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Let's โฆ
Boston Scientific (BSX) closed the most recent trading day at $43.10, moving -4.14% from the previous trading session. This change lagged the S&P 500's 0.59% loss on the day. Meanwhile, the Dow experienced a drop of 0.6%, and the technology-dominated Nasdaq saw a decrease โฆ
Boston Scientific said Tuesday a cybersecurity incident is likely to have a material impact on its third-quarter and full-year results. Continue Reading
Boston Scientific (BSX) flagged its inability to meet its near-term financial outlooks amid a "mater PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have โฆ
Sept 8 (Reuters) - Boston Scientific said on Tuesday it no longer expects to meet its previously issued third-quarter and full-year โ2026 sales and adjusted profit forecasts, after a cybersecurity incident disrupted โthe medical device maker's global operations. An unauthorized activity on some of โฆ
On this episode of Stock Movers:- Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study.- Boston Scientific (BSX) shares are moving on news it said that โฆ
Boston Scientific stock falls as the medical device maker says a recent cyberattack may make it hard to hit quarterly and full-year guidance targets. Continue Reading
Boston Scientific BSX has entered the second half of 2026 with more pressure than expected as weakness in two important businesses weighs on its near-term performance. WATCHMAN has been hurt by a sharp slowdown in the U.S. market, with clinical evidence affecting referral patterns. โฆ
Sept 8 (Reuters) - Boston Scientific said on Tuesday it no longer expects to meet its previously issued third-quarter and full-year โ2026 sales and adjusted profit forecasts, after a cybersecurity incident disrupted โthe medical device maker's global operations. An unauthorized activity on some of โฆ
Boston Scientific (BSX) identified a cybersecurity incident affecting certain information technology PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in
[Boston Scientific office building in Silicon Valley] Sundry Photography/iStock Editorial via Getty Images Boston Scientific (BSX [https://seekingalpha.com/symbol/BSX]) said a cybersecurity incident discovered on Aug. 25 is likely to have a material impact on third-quarter and full-year 2026 results, and the company now expects it โฆ
Photo by kravaivan11 on Pixabay While two high-profile segments - WATCHMAN and Electrophysiology - have stumbled, the market is overlooking the company's core stability. Business units representing roughly 75% of revenue are performing consistently with their historical track record, though this durable base's near-term โฆ
[Boston Scientific office building in Silicon Valley] Sundry Photography/iStock Editorial via Getty Images Boston Scientific (BSX [https://seekingalpha.com/symbol/BSX]) traded higher on Friday after the cardiac device maker said it has begun restoring shipping capabilities for most of its products across its major distribution centers worldwide โฆ
Boston Scientific BSX saw continued strength in its Interventional Cardiology and Vascular Therapies ("ICVT") business in the second quarter of 2026, with sales up 15% year over year. Interventional Cardiology led the performance, benefiting from double-digit growth in coronary therapies, with continued strength in โฆ
Boston Scientific (BSX) closed the most recent trading day at $46.95, moving -2.94% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 1.06%. At the same time, the Dow added 1.18%, and the tech-heavy Nasdaq gained 1.4%. โฆ
Boston Scientific (BSX) is back in focus after a series of voluntary global recalls affecting its ENROUTE Transcarotid Neuroprotection Systems and OverStitch Suture Cinch devices, along with a separate cybersecurity incident that has disrupted operations and lowered 2026 guidance. Against this backdrop of recalls โฆ
Boston Scientific (NYSE: BSX) has initiated multiple worldwide product recalls, including a Class I recall of its ENROUTE Transcarotid Neuroprotection System due to risks of arterial sheath tip separation. The company has also begun Class II recalls of certain OverStitch Suture Cinch endoscopic devices, โฆ
Boston Scientific stock has had a steep year, with a sharp share price decline set against valuation checks that point to a potentially cheap entry point based on intrinsic value and market multiples. The stock now screens as undervalued on both a Discounted Cash โฆ
Boston Scientific sign at manufacturer of medical devices Silicon Valley office By MichaelVi With a market cap of $69.7 billion, Boston Scientific Corporation (BSX) is a global medical technology leader focused on developing innovative solutions that improve patient health and transform lives. The company โฆ
It has been about a month since the last earnings report for Boston Scientific (BSX). Shares have added about 1.5% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leading up to its โฆ
Photo by TBIT on Pixabay U.S. electrophysiology growth slowed sharply and standalone WATCHMAN referrals declined in the same window, leaving the rest of Boston Scientific unable to maintain its growth-stock multiple Boston Scientific (BSX) shares have fallen 52.6% since late November 2025, while the โฆ
Boston Scientific (NYSE: BSX) reports a major cyberattack that is disrupting global operations and access to key IT systems. The company says the incident is impairing its ability to process customer orders worldwide and is still ongoing. Boston Scientific has activated its incident response โฆ
Search by ticker symbol or company name and select a result to open its chart.
Start typing to find a stock or ETF.
Choose one or more countries for market search, or include every covered market.
Currently searching United States